4//SEC Filing
DENKHAUS DONALD A 4
Accession 0001161697-25-000048
CIK 0001369568other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 5:00 PM ET
Size
7.2 KB
Accession
0001161697-25-000048
Insider Transaction Report
Form 4
DENKHAUS DONALD A
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.001 per share
2025-01-08$2.24/sh+50,000$112,000→ 491,079 total - Exercise/Conversion
Options to purchase common stock
2025-01-08−50,000→ 162,274 totalExercise: $2.24Exp: 2025-12-19→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]Derivative securities vested in three equal tranches on December 19, 2019, 2020 and 2021.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001278439
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 5:00 PM ET
- Size
- 7.2 KB